Tom F.W. Wolfs

8.3k total citations · 1 hit paper
134 papers, 5.1k citations indexed

About

Tom F.W. Wolfs is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tom F.W. Wolfs has authored 134 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Epidemiology, 54 papers in Infectious Diseases and 34 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tom F.W. Wolfs's work include Respiratory viral infections research (26 papers), HIV Research and Treatment (24 papers) and Cystic Fibrosis Research Advances (23 papers). Tom F.W. Wolfs is often cited by papers focused on Respiratory viral infections research (26 papers), HIV Research and Treatment (24 papers) and Cystic Fibrosis Research Advances (23 papers). Tom F.W. Wolfs collaborates with scholars based in Netherlands, United States and Germany. Tom F.W. Wolfs's co-authors include Jan L. L. Kimpen, Cornelis K. van der Ent, André Fleer, Jaap Goudsmit, Gabriël Zwart, Margreet Bakker, Jeanne-Marie Hament, Bart E. van Ewijk, Jaap Goudsmit and Robert M. May and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Tom F.W. Wolfs

127 papers receiving 5.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis

2016 508 citations Paul D. van der Linden, Stephanie Natsch et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Tom F.W. Wolfs	2.2k	1.9k	1.3k	1.0k	519	134	5.1k
Robert A. Salata	2.5k 1.1×	3.7k 1.9×	1.1k 0.8×	427 0.4×	565 1.1×	239	8.3k
Patricia M. Flynn	2.9k 1.3×	3.6k 1.9×	984 0.8×	675 0.7×	229 0.4×	133	7.7k
Stephen I. Pelton	6.6k 3.0×	1.5k 0.8×	1.1k 0.8×	1.2k 1.2×	942 1.8×	241	10.0k
Maurizio de Martino	2.5k 1.1×	2.4k 1.3×	797 0.6×	682 0.7×	704 1.4×	244	6.2k
María Ángeles Marcos	4.4k 2.0×	1.5k 0.8×	516 0.4×	796 0.8×	527 1.0×	180	6.4k
Ram Yogev	4.2k 1.9×	3.4k 1.8×	1.5k 1.2×	1.1k 1.1×	928 1.8×	298	9.1k
Paul Krogstad	970 0.4×	2.0k 1.1×	1.7k 1.3×	208 0.2×	621 1.2×	98	3.9k
Bernd Salzberger	2.0k 0.9×	2.8k 1.5×	1.1k 0.9×	268 0.3×	413 0.8×	245	6.1k
Andy I. M. Hoepelman	5.3k 2.4×	4.1k 2.1×	1.3k 1.0×	683 0.7×	1.1k 2.0×	255	10.5k
Eric Van Wijngaerden	2.8k 1.3×	3.0k 1.6×	790 0.6×	809 0.8×	119 0.2×	121	6.7k

Countries citing papers authored by Tom F.W. Wolfs

Since Specialization

Citations

This map shows the geographic impact of Tom F.W. Wolfs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom F.W. Wolfs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom F.W. Wolfs more than expected).

Fields of papers citing papers by Tom F.W. Wolfs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom F.W. Wolfs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom F.W. Wolfs. The network helps show where Tom F.W. Wolfs may publish in the future.

Co-authorship network of co-authors of Tom F.W. Wolfs

This figure shows the co-authorship network connecting the top 25 collaborators of Tom F.W. Wolfs. A scholar is included among the top collaborators of Tom F.W. Wolfs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom F.W. Wolfs. Tom F.W. Wolfs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bruggen, Tjomme van der, Matthias Sipiczki, Wim J. E. Tissing, et al.. (2025). Expansion of the Candidozyma haemuli Species Complex - The Novel Species Candidozyma molenica, Isolated from Clinical and Environmental Sources. Mycopathologia. 190(5). 81–81.

Tissing, Wim J. E., et al.. (2024). Clinical presentation and outcome of invasive mould disease in paediatric patients with acute lymphoblastic leukaemia. SHILAP Revista de lepidopterología. 3. 100143–100143. 3 indexed citations

Wolfs, Tom F.W., et al.. (2024). How accurate is high-resolution computed tomography of the chest in differentiating between pulmonary invasive fungal infections and other pulmonary infections in children with cancer?. Pediatric Radiology. 55(2). 268–279. 1 indexed citations

Wolfs, Tom F.W., Rob ter Heine, Eline W. Muilwijk, et al.. (2023). Pharmacokinetic investigations of isavuconazole in paediatric cancer patients show reduced exposure of isavuconazole after opening capsules for administration via a nasogastric tube. Journal of Antimicrobial Chemotherapy. 78(12). 2886–2889. 3 indexed citations

Wolfs, Tom F.W., Eline W. Muilwijk, Marta Fiocco, et al.. (2023). Micafungin twice-a-week for prophylaxis of invasive Aspergillus infections in children with acute lymphoblastic leukaemia: A controlled cohort study. International Journal of Antimicrobial Agents. 63(1). 107058–107058. 6 indexed citations

Boyd, Anders, Stephanie Natsch, Jan M. Prins, et al.. (2023). A national antimicrobial guide with local, customizable versions: how is it used? A two-year analysis. JAC-Antimicrobial Resistance. 5(6). dlad136–dlad136. 1 indexed citations

Steeg, Alida F. W. van der, et al.. (2023). Central Venous Catheter-related Bloodstream Infections Caused by Enterobacterales in Pediatric Oncology Patients: Catheter Salvage or Removal. The Pediatric Infectious Disease Journal. 43(1). 49–55. 3 indexed citations

Tissing, Wim J. E., et al.. (2021). Clinical Pharmacokinetics of Triazoles in Pediatric Patients. Clinical Pharmacokinetics. 60(9). 1103–1147. 17 indexed citations

Wolfs, Tom F.W., et al.. (2021). Pharmacokinetic evaluation of twice-a-week micafungin for prophylaxis of invasive fungal disease in children with acute lymphoblastic leukaemia: a prospective observational cohort study. Journal of Antimicrobial Chemotherapy. 77(3). 699–703. 7 indexed citations

10.

Vries, Linda S. de, Marian J. Jongmans, Corine Koopman-Esseboom, et al.. (2018). Outcome of Preterm Infants With Postnatal Cytomegalovirus Infection. PEDIATRICS. 141(2). 71 indexed citations

11.

Berrevoets, Marvin A. H., Martine G. Caris, Jaap ten Oever, et al.. (2018). Praktijkgids - antimicrobial Stewardship in Nederland. Data Archiving and Networked Services (DANS). 1 indexed citations

12.

Ewijk, Bart E. van, et al.. (2015). Frequency and Duration of Rhinovirus Infections in Children With Cystic Fibrosis and Healthy Controls. The Pediatric Infectious Disease Journal. 35(4). 379–383. 32 indexed citations

13.

Mansfeld, Rosa van, Rob J. L. Willems, R.W. Brimicombe, et al.. (2009). Pseudomonas aeruginosa Genotype Prevalence in Dutch Cystic Fibrosis Patients and Age Dependency of Colonization by Various P. aeruginosa Sequence Types. Journal of Clinical Microbiology. 47(12). 4096–4101. 52 indexed citations

14.

Vrisekoop, Nienke, Rogier van Gent, Sigrid A. Otto, et al.. (2008). Restoration of the CD4 T Cell Compartment after Long-Term Highly Active Antiretroviral Therapy without Phenotypical Signs of Accelerated Immunological Aging. The Journal of Immunology. 181(2). 1573–1581. 53 indexed citations

15.

Tramper‐Stranders, Gerdien A., Tom F.W. Wolfs, Jan L. L. Kimpen, et al.. (2008). Pseudomonas aeruginosa diversity in distinct paediatric patient groups. Clinical Microbiology and Infection. 14(10). 935–941. 14 indexed citations

16.

Hament, Jeanne-Marie, Piet C. Aerts, André Fleer, et al.. (2005). Direct Binding of Respiratory Syncytial Virus to Pneumococci: A Phenomenon That Enhances Both Pneumococcal Adherence to Human Epithelial Cells and Pneumococcal Invasiveness in a Murine Model. Pediatric Research. 58(6). 1198–1203. 82 indexed citations

17.

Ewijk, Bart E. van, Marieke M. van der Zalm, Tom F.W. Wolfs, & Cornelis K. van der Ent. (2005). Viral respiratory infections in cystic fibrosis. Journal of Cystic Fibrosis. 4. 31–36. 67 indexed citations

18.

Rossum, Annemarie M. C. van, Alina S Bergshoeff, Pieter L. A. Fraaij, et al.. (2002). Therapeutic drug monitoring of indinavir and nelfinavir to assess adherence to therapy in HIV-1 infected children.. The Pediatric Infectious Disease Journal.

19.

Hament, Jeanne-Marie, Jan L. L. Kimpen, André Fleer, & Tom F.W. Wolfs. (1999). Respiratory viral infection predisposing for bacterial disease: a concise review. FEMS Immunology & Medical Microbiology. 26(3-4). 189–195. 232 indexed citations

20.

Zwart, Gabriël, et al.. (1992). Characterization of the Specificity of the Human Antibody Response to the V3 Neutralization Domain of HIV-1. AIDS Research and Human Retroviruses. 8(11). 1897–1908. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact